More than 400 million people currently suffer from some type of diabetes, a figure that represents 1 in 11 adults worldwide ...

In a paper published in Science Bulletin, multi-omics analyses comprising of lipidomics (439 lipids), sterolomics (22 ...

Since risk comes from decisions on limited information, Pheast builds in flexibility to adjust processes as information becomes available.

Enveric Biosciences’ EVM301 portfolio receives five additional US patents: Cambridge, Massachusetts Wednesday, November 6, 2024, 17:00 Hrs [IST] Enveric Biosciences, a biotechno ...

This study is led by Professor Rong Hu's team from the Department of Neurosurgery and Key Laboratory of Neurotrama, Southwest Hospital, Third Military ...

When you talk about carbohydrates, most people's minds immediately go to the culinary world. But they're also the central ...

Notably, 51% of patients reported not regularly testing their blood sugar levels at home, citing reasons such as inconvenience or a belief that monitoring is unnecessary. Furthermore, the survey ...

Freynhagen et al. [20] studied pregabalin in patients with a primary diagnosis of painful diabetic peripheral neuropathy (type 1 or 2 diabetes mellitus with a glycosylated hemoglobin value of ≤ ...

Data from National Health and Nutrition Examination Survey shows that US patients with obesity are at significantly high risk of experiencing chronic pain.

The AYUSH ministry aims to combine traditional and modern medicine in order to make treatments more effective and improve patient outcomes ...

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders, today ...

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands Correspondence to Professor Adriaan A Voors, Department of Cardiology, Thorax Center, ...